Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France-Reference-Cited by-同舟云学术

Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France

Published:2024-09-10 Issue:5 Volume:103 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Moisset Xavier¹^ORCID,Leray Emmanuelle¹^ORCID,Chenaf Chouki¹,Taithe Frederic¹,Vukusic Sandra¹^ORCID,Mulliez Aurelien¹,Clavelou Pierre¹^ORCID

Affiliation:

1. From the Université Clermont Auvergne (X.M., C.C., P.C.), CHU Clermont-Ferrand, Inserm, Neuro-Dol; Univ Rennes (E.L.), EHESP, CNRS, Inserm, ARENES UMR 6051, RSMS U 1309; Service de Neurologie (F.T.), CHU Clermont-Ferrand; Service de Neurologie (S.V.), Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Centre de Ressources, Recherche et Compétence sur la Sclérose en Plaques et Fondation Eugène Devic EDMUS pour la Sclé; and Biostatistics Unit (A.M.), DRCI, CHU Clermont-Ferrand, France.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000209662

Reference28 articles.

1. COVID-19 Severity in Multiple Sclerosis

2. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19

3. CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review

4. To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection

5. Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Risk of Multiple Sclerosis Relapse After Vaccination;Neurology;2024-09-10